Lincoln Therapeutics
UEI: D47ZV9DNQWL5
• CAGE: 996K4
Overview
Awardee Type
Parent
Name
Lincoln Therapeutics
Headquarters
Lake Forest, IL
United States
United States
Most Recent Award
Aug. 1, 2023
Calculating
Federal grant recipient
LINCOLN THERAPEUTICS, LLC
dba LINCOLN THERAPEUTICS LLC
(UEI D47ZV9DNQWL5, CAGE 996K4)
is headquartered in Lake Forest IL.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The sole proprietorship
was founded in April 2021 and
federally registered in
February 2022.
Federal Award Analysis
Lincoln Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
LINCOLN THERAPEUTICS, LLC
DBA
LINCOLN THERAPEUTICS LLC
UEI
D47ZV9DNQWL5
CAGE Code
996K4
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Sole Proprietorship
Purpose of Registration
Federal Contracts and Assistance
Date Founded
April 9, 2021
Initial Registration
Feb. 9, 2022
Last Registration
Sept. 20, 2024
Registration Activation
Sept. 20, 2024
Registration Expiration
Sept. 20, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Limited Liability Company
State of Incorporation
ND
Country of Incorporation
USA
Employees
Not Available
Reported NAICS
Accepts Credit Cards
No
People
Vendor contacts at Lincoln Therapeutics
Subgrant Awards
Lincoln Therapeutics subgrant awards
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
Lincoln Therapeutics